Master Soumyajit, a 3 year old boy, 1st order child born of a non-consanguineous marriage from Kolkata, West Bengal presented with complaints of severe progressive paleness and lethargy noticed since 6 months of age, requiring regular packed red blood cell transfusions every 3 to 4 weeks for the past 2 years, gradual swelling of the abdomen for 1.5 years, and abnormal broadening of facial bones for 1 year.

HOPI

The history is dated back to 6 months of age when the mother first noticed that the child was becoming pale, listless, and uninterested in surroundings.

• Onset & Transfusion Dependence:
  • Child was seemingly healthy till 6 months of age, when mother noticed progressive pallor of the face, palms, and soles.
  • Child became irritable, fatigued quickly during feeds, and stopped gaining weight.
  • At 9 months of age, during an episode of viral fever, a local physician documented a Hemoglobin of $4.2\text{ g/dL}$. The child received his first blood transfusion and was diagnosed with Beta-Thalassemia Major.
  • Since then, he has been on regular lifelong blood transfusions every 3 to 4 weeks, receiving leukocyte-filtered packed red blood cells. Total transfusions received till date: 26 units.
  • Mother notes that towards the end of the 3-week cycle (pre-transfusion), the child becomes pale, breathless on mild exertion, and loses his appetite.
• Abdominal Distension (Hepatosplenomegaly):
  • Progressive increase in abdominal girth noticed over the past 1.5 years.
  • Mother noticed a hard lump under the left ribs that gradually enlarged downward toward the navel (splenomegaly) Reflects dual pathology: chronic extramedullary hematopoiesis and intense reticuloendothelial clearance of defective, precipitated alpha-chain RBCs.
• Skeletal & Facial Changes (Extramedullary Hematopoiesis):
  • Over the past 12 months, parents noticed a striking change in the child's facial appearance.
  • Forehead became prominent and bulging, cheekbones became unusually elevated, and the bridge of the nose appeared flattened (chipmunk facies) Massive compensatory expansion of the erythroid marrow space (up to 20-30 times normal) within the skull and facial bones causes diploic space widening and cortical bone thinning.
• Iron Overload & Chelation History:
  • Child has received ~26 transfusions ($>120\text{ mL/kg}$ cumulative PRBC).
  • Serum Ferritin measured 2 months ago was $1,850\text{ ng/mL}$ (elevated; threshold to start chelation is $>1,000\text{ ng/mL}$).
  • Started on oral Deferasirox ($20\text{ mg/kg/day}$) 4 months ago; parents report irregular compliance due to gastrointestinal upset.
• Negative History:
  • No history of cola-colored or black urine Excludes acute intravascular hemolysis / hemoglobinuria.
  • No history of severe bone pain, dactylitis (swelling of hands/feet), or acute chest pain Rules out vaso-occlusive crisis of Sickle Cell Anemia.
  • No history of sudden deepening of pallor with high fever Rules out Parvovirus B19 aplastic crisis.
  • No history of transfusion reactions (urticaria, chills, rigors, dyspnea) during transfusions.
  • No history of bleeding from gums, petechiae, or purpuric spots.

Past History

• Diagnosed with Beta-Thalassemia Major at 9 months of age via Hemoglobin HPLC.
• Transfused every 3-4 weeks since age 9 months.
• No history of splenectomy or cholecystectomy.

Family history

• Born of a non-consanguineous marriage.
• Father 33 years, office clerk; mother 29 years, homemaker; both are confirmed carriers of Beta-Thalassemia Trait (Minor).
• Family Lineage: Maternal uncle suffered from severe childhood anemia and died at 5 years of age (undiagnosed thalassemia major).
• Proband is an only child; parents received antenatal counseling for future pregnancies.

Immunization history

• Fully immunized as per the National Immunization Schedule (UIP) up to 3 years.
• Additional vaccines: Received Hepatitis B vaccine (full 3-dose course + booster) and Hepatitis A vaccine (mandatory prior to frequent transfusions).
• Pneumococcal and Meningococcal vaccines planned in view of future splenectomy risk.

Dietary history

• Consumes a soft home diet consisting of rice, dal, and vegetables.
• Parents strictly avoid iron-rich foods (liver, red meat, green leafy vegetables) and iron-fortified cereals.
• Mother gives black tea with meals (tannins inhibit intestinal non-heme iron absorption).

Food Item	Quantity	Calories (kcal)	Protein (g)
Boiled Rice	120 g	156	3.2
Moong Dal	1 katori	90	5.5
Cow's Milk (toned)	250 mL	150	8.0
Mashed Vegetables	1 cup	70	1.4
Total Observed Daily Intake	—	466 kcal	18.1 g

24-Hour Recall Deficit Analysis

$$ \text{Ideal Body Weight (IBW for 3 years, 50th centile WHO)} = 14.3\text{ kg} $$

Nutrient	Expected Intake (ICMR-NIN 2024 for IBW 14.3 kg)	Observed Intake	Deficit	Percentage Deficit
Energy (kcal)	$14.3\text{ kg} \times 80\text{ kcal/kg} = 1144\text{ kcal}$	466 kcal	678 kcal	59.3% Deficit
Protein (g)	$14.3\text{ kg} \times 1.1\text{ g/kg} = 15.7\text{ g}$	18.1 g	Nil (Adequate)	0% Deficit

The expected calories and proteins should be calculated from the ideal body weight, not from current weight.

Socioeconomic and KAP

• Belongs to Modified BG Prasad Socioeconomic Class III (Middle Class).
• Urban residence in Kolkata with ready access to a thalassemia transfusion center.
• Parents understand that transfusions sustain life, but are financially stressed by chelation costs and anxious regarding curative stem cell transplantation.

Summary of History

Master Soumyajit, a 3-year-old boy, 1st order child born of non-consanguineous parents who are both beta-thalassemia trait carriers from Kolkata, presented with severe progressive pallor since 6 months of age, transfusion dependence requiring 3-4 weekly PRBC transfusions for 2 years (total 26 units), progressive splenomegaly, hemolytic bone changes, and elevated ferritin ($1,850\text{ ng/mL}$), without features of sickling vaso-occlusive crisis, aplastic crisis, or transfusion reactions.

I would like to think of a hereditary hemolytic anemia secondary to Beta-Thalassemia Major, transfusion-dependent, complicated by extramedullary hematopoiesis (splenomegaly, hemolytic facies), secondary hemosiderosis, and severe failure to thrive.

General head to toe examination

• Child Behavioral State: Quiet wakefulness (Prechtl State 3), listless, cooperative.
• Vitals:
  • Pulse Rate: 118 beats/minute (resting tachycardia), regular, bounding / water-hammer character.
  • Respiratory Rate: 26 breaths/minute, regular, abdominothoracic.
  • Blood Pressure: $98/52\text{ mmHg}$ (wide pulse pressure $\approx 46\text{ mmHg}$ indicating a hyperdynamic circulatory state).
  • Temperature: $36.8^\circ\text{C}$ (afebrile).
• Anthropometry:

Parameter	Observed	Expected (50th WHO)	Z-score / Centile	Inference
Weight	11.0 kg	14.3 kg	$< -2\text{ SD}$	Moderate Underweight
Height	87 cm	96 cm	$< -2\text{ SD}$	Moderate Stunting
Head Circumference	49.0 cm	49.5 cm	Normal	Normal head growth

• Craniofacial & Hemolytic Facies:
  • Classical "Chipmunk / Thalassemic Facies":
    • Frontal bossing and prominent parietal eminences.
    • Depressed, flattened nasal bridge.
    • Prominent malar eminences (malar prominence).
    • Maxillary hyperplasia with upward retraction of the upper lip exposing protruding upper incisors and dental malocclusion.
• General Findings:
  • Pallor: Severe pallor in conjunctiva, mucosal surfaces, palms, and nail beds.
  • Icterus: Mild lemon-yellow icterus in the superior bulbar conjunctiva (unconjugated hyperbilirubinemia from chronic extravascular hemolysis).
  • Skin Pigmentation: Generalized grayish-bronze / muddy skin discoloration (cutaneous hemosiderosis / melanin stimulation).
  • Lymphadenopathy / Edema / Cyanosis: Absent.

Systemic Examination

Abdomen

• Inspection:
  • Protuberant, distended abdomen with prominent superficial non-tortuous veins.
  • Umbilicus central, stretched; no caput medusae.
• Palpation:
  • Soft, non-tender throughout; no guarding.
  • Spleen:
    • Massive Splenomegaly: Palpable 6.0 cm below the left costal margin along its long axis toward the right iliac fossa.
    • Firm consistency, smooth surface, prominent splenic notch palpable on anterior border, non-tender, no friction rub.
  • Liver:
    • Hepatomegaly: Palpable 4.0 cm below right costal margin in midclavicular line.
    • Firm in consistency, smooth surface, rounded edge, non-tender; total Liver Span is 11.0 cm (normal $\approx 7.5-8\text{ cm}$).
  • Kidneys: Not palpable.
• Percussion: Dull over organomegaly; central tympany; no shifting dullness (no ascites).
• Auscultation: Normal bowel sounds; no venous hum or bruits.

Cardiovascular System (CVS)

• Precordium hyperdynamic; visible apex beat in 5th intercostal space outside the midclavicular line.
• Normal $S_1$ and $S_2$; Grade 3/6 ejection systolic hemic murmur heard best over the pulmonary area and left sternal border (turbulent flow across normal valves from severe chronic anemia).
• No gallop rhythm, JVP not elevated.

Respiratory & Central Nervous Systems

• Lungs clear bilaterally with normal vesicular breath sounds.
• CNS completely intact; alert, responsive; normal tone, power (5/5), and reflexes.

other systems

• Musculoskeletal: No active bone tenderness; extremities thin.

Summary

Master Soumyajit, a 3-year-old boy, born of non-consanguineous parents who are both beta-thalassemia carriers from Kolkata, presented with a 2-year history of transfusion dependence requiring monthly PRBC transfusions, progressive hepatosplenomegaly, and facial changes. Physical examination confirms severe pallor, lemon-yellow icterus, bronze hyperpigmentation, thalassemic chipmunk facies, hyperdynamic circulation with wide pulse pressure and a hemic murmur, marked splenomegaly (6 cm), and hepatomegaly (liver span 11 cm), with an elevated ferritin of $1,850\text{ ng/mL}$.

The clinical presentation is pathognomonic for Transfusion-Dependent Beta-Thalassemia Major, complicated by extramedullary hematopoiesis, hyperdynamic circulation, secondary hemosiderosis, and growth faltering.

Differential Diagnosis

Disease	Points IN FAVOR	Points AGAINST
Beta-Thalassemia Major	Onset in late infancy (6-12m), lifelong transfusion dependence, chipmunk facies, massive splenomegaly, HPLC confirms HbF >80%	Primary Diagnosis
HbE-Beta Thalassemia	Common in West Bengal/Assam, severe anemia, hepatosplenomegaly, hemolytic facies	HPLC demonstrates prominent HbE peak along with HbF; clinically ranges from mild non-transfusion dependent to severe
Sickle-Beta Thalassemia	Microcytic anemia, splenomegaly, consanguinity	Vaso-occlusive bone crises and dactylitis are absent; HPLC shows HbS peak; sickle solubility test negative
Hereditary Spherocytosis	Hemolytic anemia, jaundice, splenomegaly, gallstones	Autosomal dominant usually, spherocytes on blood smear, normal HPLC with elevated MCHC, negative HbF elevation
Autoimmune Hemolytic Anemia (AIHA)	Acquired severe pallor, icterus, splenomegaly	Sudden onset, lacks chipmunk facies, no microcytosis, Direct Antiglobulin Test (Coombs) is positive

Investigation Protocol & Diagnostic Workup

flowchart TD
    A["Child with Chronic Microcytic Hemolytic Anemia & Hepatosplenomegaly"] --> B["CBC, Peripheral Smear & Reticulocyte Count"]
    B --> C["Identify Severe Microcytic Hypochromic Anemia with Nucleated RBCs"]
    C --> D["Hemoglobin HPLC / Capillary Zone Electrophoresis"]
    D --> E{"HbF > 70-90% & Virtually Absent HbA?"}
    E -->|Yes| F["Confirm Beta-Thalassemia Major; Screen Both Parents (HbA2 > 3.5%)"]
    F --> G["Iron Overload Assessment: Serum Ferritin, Liver Function Tests"]
    G --> H["Imaging: Skull Radiograph (Hair-on-End Sign) & Abdominal USG"]
    H --> I["Pre-Transfusion Viral Screening: NAT for HIV, HBV, HCV"]
    I --> J["Initiate Hypertransfusion Regimen & Oral Iron Chelation (Deferasirox)"]

1. Confirmatory Hemoglobin Analysis (HPLC)

• High-Performance Liquid Chromatography (Bio-Rad Variant II):
  • HbF (Fetal Hemoglobin): Markedly elevated at $88.5\%$ (diagnostic hallmark).
  • HbA (Adult Hemoglobin): Virtually absent ($<2.0\%$) in $\beta^0/\beta^0$ or markedly reduced ($<10\%$) in $\beta^0/\beta^+$.
  • HbA2: Variable ($1.8-3.2\%$).
• Parental HPLC Screening:
  • Both father and mother demonstrate elevated $\text{HbA}_2 > 3.5\%$ (Father $5.2\%$, Mother $4.8\%$), confirming that both parents are heterozygous carriers of Beta-Thalassemia Minor.

2. Complete Blood Count & Blood Smear

• Hemoglobin (Pre-transfusion): $6.2\text{ g/dL}$.
• RBC Indices: Severe microcytosis (MCV $61.5\text{ fL}$, normal $75-87\text{ fL}$), severe hypochromia (MCH $18.2\text{ pg}$, normal $24-30\text{ pg}$), RDW markedly elevated ($26.4\%$).
• Peripheral Blood Smear: Marked anisopoikilocytosis, microcytes, hypochromia, numerous target cells (leptocytes), tear-drop cells, basophilic stippling, and numerous nucleated RBCs (erythroblasts: 38 per 100 WBCs) reflecting intense extramedullary erythropoiesis.
• Reticulocyte Count: Corrected Reticulocyte Count $3.8\%$ (elevated, but inappropriately low for the profound degree of anemia due to massive intramedullary apoptosis of erythroid precursors).

3. Iron Overload Studies

• Serum Ferritin: $1,850\text{ ng/mL}$ (target in well-chelated children is $<1,000\text{ ng/mL}$).
• Serum Iron: $210\text{ mcg/dL}$ (elevated); TIBC: $240\text{ mcg/dL}$ (decreased); Transferrin Saturation: $87.5\%$ (markedly elevated).

4. Radiological Imaging

• Skull Radiograph (Lateral View):
  • Classical "Hair-on-End" (Crew-cut) appearance: widening of the diploic space with thinning of the outer table and fine vertical striations of bone trabeculae perpendicular to the tables.
• Abdominal Ultrasound: Confirms marked homogeneous hepatosplenomegaly; no gallstones or biliary sludge visualized.

Management Plan

1. Hypertransfusion Protocol (Standard of Care)

• Target Hemoglobin: Maintain pre-transfusion Hemoglobin strictly between $9.5$ and $10.5\text{ g/dL}$ (post-transfusion Hb $13.5-14.0\text{ g/dL}$).
• Clinical Rationale: Maintaining pre-transfusion $\text{Hb} > 9.5\text{ g/dL}$ completely suppresses endogenous ineffective erythropoiesis, prevents skeletal facial deformities, halts progressive hepatosplenomegaly, prevents cardiomegaly, and supports normal somatic growth.
• Transfusion Specification:
  • Transfuse Leukocyte-Depleted (leukofiltered) Packed Red Blood Cells (PRBC), crossmatch-compatible, phenotype-matched for Rh and Kell antigens, screened by Nucleic Acid Testing (NAT) for HIV, HBV, and HCV.
  • Dose: $10-15\text{ mL/kg}$ per transfusion, infused over 3–4 hours every 3 to 4 weeks.

2. Iron Chelation Therapy

• Initiation Criteria: Initiated when Serum Ferritin $>1,000\text{ ng/mL}$ OR after receiving $>10-20$ transfusions (typically around 2–3 years of age).
• First-Line Oral Chelator:
  • Deferasirox (DFX): Administer once daily at $20-30\text{ mg/kg/day}$ (as dispersible tablets dissolved in water/apple juice on an empty stomach 30 minutes before food).
  • Monitoring: Monthly serum creatinine and urine protein-to-creatinine ratio (renal tubular toxicity), monthly ALT/AST, and quarterly serum ferritin.
• Alternative / Combination Chelators (for Severe Iron Overload):
  • Deferiprone (DFP): Oral $75-100\text{ mg/kg/day}$ divided tid; highly effective for cardiac iron removal; requires weekly Absolute Neutrophil Count (ANC) monitoring due to the risk of agranulocytosis.
  • Deferoxamine (DFO): Subcutaneous infusion $30-50\text{ mg/kg/day}$ over 8–12 hours using a portable infusion pump 5–7 nights/week.

3. Adjuvant Medical & Nutritional Therapy

• Folic Acid: Daily oral supplementation ($1-2\text{ mg/day}$) to sustain active erythropoiesis.
• Strict Avoidance of Iron: Prohibit all iron-containing tonics, vitamin syrups with iron, and iron-fortified baby foods.
• Dietary Advice: Encourage drinking black tea with meals (tea polyphenols bind dietary iron).

4. Definitive Curative Therapy

• Allogeneic Hematopoietic Stem Cell Transplantation (HSCT):
  • The only widely established curative modality.
  • Best outcomes achieved with an HLA-identical matched sibling donor (MSD) prior to the onset of severe iron overload and hepatomegaly (Pesaro Risk Class 1: disease-free survival $>90\%$).
• Novel Gene Therapy: Autologous CD34+ cells transduced with lentiviral vector expressing $\beta$-globin (Betibeglogene autotemcel) or CRISPR-Cas9 gene editing (Exagamglogene autotemcel / Casgevy).

5. Indications for Splenectomy (Deferred Ideally Until >5-6 Years)

• Reserved strictly for children with annual PRBC transfusion requirements exceeding $>200-220\text{ mL/kg/year}$, symptomatic hypersplenism (worsening leukopenia/thrombocytopenia), or massive mechanical discomfort.
• Mandatory pre-splenectomy immunization against Streptococcus pneumoniae (PCV13 + PPSV23), Neisseria meningitidis (MenACWY), and Haemophilus influenzae type b (Hib) at least 4 weeks prior, followed by lifelong daily oral Penicillin V prophylaxis.